Wockhardt is involved in the healthcare sector, specifically in pharmaceuticals and biotechnology. The company is self-described as complying with specific regulatory requirements in India.

Wockhardt Limited

Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, the United Kingdom, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules. The company's biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. It also provides contract manufacturing services for sterile injectables, lyophilization, and other dosage forms; and research services. The company was founded in 1967 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.

COM:WOCKHARDT

Wockhardt

Last Close

1,436.50

14/02 10:00

Market Cap

135.95B

Beta: -

Volume Today

548.61K

Avg: -

name

homepage url

country

employee count

sector

industry

revenue

Description

competitor of

Metrics